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INTRODUCTION
The etiology of Churg-Strauss syndrome (CSS) is 
not well understood. Some case reports have suggested 
allergic desensitization,1 exposure to pigeons,2 cocaine use,3 
leukotriene receptor antagonist treatment4,5 and hepatitis 
vaccination6,7 as putative etiological agents.
In the present study, we report the case of a patient who 
developed CSS after becoming infected with hepatitis B 
virus (HBV).
CASE DESCRIPTION
A 64-year-old Caucasian female who worked as a nurse 
technician was admitted to the Hospital das Clínicas da 
Faculdade de Medicina da Universidade de São Paulo after 
suffering from fatigue, malaise and fever for 30 days. She 
exhibited palpable purpuras in the legs and feet and reported 
having numbness in her feet fifteen days prior to the onset 
of her symptoms.
The patient had suffered from asthma since the age of 
15, for which she used inhaled corticosteroids. She had 
never used a leukotriene receptor antagonist or illicit drugs, 
such as cocaine, nor had she received a prophylactic HBV 
vaccination. However, six years earlier, she was accidentally 
punctured in the arm with a needle that was potentially 
contaminated with HBV.
A neurological examination revealed anesthesia in 
the left superficial peroneal and right plantar nerves, 
but no motor deficit or abnormalities in her reflexes. A 
blood chemistry analysis revealed that the patient had 
leukocytosis (25,210/mm3), with 68% of white blood cells 
being eosinophils, and she exhibited serum IgE levels of 
829 mg/dL. In addition, an examination of the patient’s 
excrement gave a normal result. Her liver enzyme levels 
were slightly elevated. HBV serology revealed positivity 
for IgM anti-HBc and anti-HBe antibodies and HBsAg, the 
absence of anti-HBs antibodies and HBeAg and no HIV or 
hepatitis C infection. Parasitological tests were negative. 
Additional studies revealed that the patient was negative 
for anti-nuclear. The anti -rheumatoid factor was 211U/L 
(NL: <25U/L) and lacked serum cryoglobulins. However, 
indirect immunofluorescence analysis indicated that she 
had low titers of p-ANCA (this result was not confirmed 
by testing for anti-MPO by ELISA). An echocardiogram 
revealed a moderate pericardial effusion with no other 
alterations. Spirometry showed mild obstructive airway 
disease. High-resolution computed tomography revealed a 
thickening of the bronchial walls and extensive areas of air 
capture, paranasal sinuses with diffuse mucosal thickening 
and polyps in the superior nasal meatus.
An electroneuromyography revealed mononeuritis 
multiplex in the lower extremities. Upon performing a skin 
biopsy, we found that the patient presented leukocytoclastic 
vasculitis with eosinophilic infiltration of the blood 
vessel walls, but there was no evidence of granuloma. 
An abdominal ultrasound indicated that her liver was 
heterogeneous, and a liver biopsy confirmed that she had 
active chronic HBV infection. While there were no signs of 
cirrhosis, she did present intense inflammatory eosinophilic 
infiltration of the periportal spaces (Figure 1) and focal 
fibrinoid necrosis of the vessels. 
The patient had no proteinuria, no urinary sediment 
alterations and no creatinine elevation.
The patient was treated with 150 mg/day of lamivudine 336
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and 1 mg/kg/day of prednisone, after which she achieved 
full recovery and regained normal liver function with no 
signs of viral replication. Therefore, cyclophosphamide and 
interferon treatment were not necessary.
Aside from the presence of vasculitis and a history 
of allergy, the patient had no infections and no history of 
drug use; therefore, it is unlikely that she suffered from 
hypereosinophilic syndrome. The patient was diagnosed 
with CSS according to the criteria of the American College 
of Rheumatology.8 We considered her positive response 
to therapy and full recovery from pericardial effusion as a 
manifestation of cardiac involvement secondary to CSS.
DISCUSSION
In the present work, we report a case of CSS that 
developed in a patient infected with HBV after she suffered 
an accidental puncture with a needle contaminated with 
HBV. Six years after this incident, she developed CSS, 
which may have been coincidental or associated with HBV 
infection.
To date, there has been only one case report of a patient 
who harbored a natural HBV infection and suffered from 
CSS that affected the colon.9 However, that report did not 
investigate whether the HBV infection triggered the onset 
of CSS. Another report described a case of CSS that was 
associated with both HBV and HIV infections.10
In conclusion, we have described a case of CSS that was 
associated with active chronic HBV infection. It is likely that 
chronic HBV infection triggered CSS in this patient.
Figure 1 - Liver biopsy sections of active chronic hepatitis B infection 
without cirrhosis, but with intense inflammatory eosinophilic infiltration 
into the vessels and focal fibrinoid necrosis (hematoxylin and eosin, original 
magnification 40X)
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